The History of Terrorism
Preview
Open in TheBrain
Cleara Biotech
Parents
Biotech
Peter de Keizer
Children
Cleara Biotech, formed this June backed by $3m in funding and based in the Netherlands. In addition, Scottish company CellAge, also founded in 2016, has raised about $100,000 to date, partly through a crowdfunding campaign.
Cleara's approach, meanwhile, which uses an engineered peptide molecule, targets a particular subtype of senescent cell, which, says scientific co-founder Peter de Keizer, will make it safer.